Ignite Creation Date:
2025-12-25 @ 3:13 AM
Ignite Modification Date:
2026-03-01 @ 6:02 AM
Study NCT ID:
NCT02429505
Status:
WITHDRAWN
Last Update Posted:
2020-08-28
First Post:
2015-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry
Sponsor:
Knight Therapeutics (USA) Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IMP 2127-4
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None